Annual report pursuant to Section 13 and 15(d)

Warrants and Derivative Liabilities (Detail Textuals)

v3.19.1
Warrants and Derivative Liabilities (Detail Textuals)
 1 Months Ended 12 Months Ended
Feb. 28, 2018
USD ($)
Investor
$ / shares
shares
Feb. 16, 2018
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
Jan. 19, 2018
USD ($)
$ / shares
shares
Dec. 31, 2017
USD ($)
Jan. 31, 2017
shares
Class of Warrant or Right [Line Items]            
Financing transaction costs | $     $ 137,192      
Warrants            
Class of Warrant or Right [Line Items]            
Value of common stock called by warrants | $ $ 30,000          
Total number of warrants issued | shares 125,000          
Number of investors | Investor 1          
Warrants | Emerald Health Sciences Inc            
Class of Warrant or Right [Line Items]            
Value of common stock called by warrants | $ $ 3,400,000     $ 40,800,000    
Total number of warrants issued | shares 44,200,000     44,200,000    
Warrant exercise price | $ / shares $ 0.10     $ 0.10    
Term of warrant 5 years 5 years        
Series D Preferred Stock | Warrants            
Class of Warrant or Right [Line Items]            
Value of common stock called by warrants | $         $ 115,200  
Total number of warrants issued | shares           480,000
Securities purchase agreement | Emerald Health Sciences Inc            
Class of Warrant or Right [Line Items]            
Total number of warrants issued | shares   20,400,000   20,400,000    
Warrant exercise price | $ / shares   $ 0.10   $ 0.10    
Securities purchase agreement | Accredited Investor | Emerald Health Sciences Inc            
Class of Warrant or Right [Line Items]            
Total number of warrants issued | shares   3,400,000        
Warrant exercise price | $ / shares   $ 0.10        
Emerald Warrant Liabilities            
Class of Warrant or Right [Line Items]            
Value of common stock called by warrants | $   $ 5,700,000   $ 4,700,000